These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 23589562)

  • 1. Renal responses to long-term carotid baroreflex activation therapy in patients with drug-resistant hypertension.
    Alnima T; de Leeuw PW; Tan FE; Kroon AA;
    Hypertension; 2013 Jun; 61(6):1334-9. PubMed ID: 23589562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sustained acute voltage-dependent blood pressure decrease with prolonged carotid baroreflex activation in therapy-resistant hypertension.
    Alnima T; Scheffers I; De Leeuw PW; Winkens B; Jongen-Vancraybex H; Tordoir JH; Schmidli J; Mohaupt MG; Allemann Y; Kroon AA
    J Hypertens; 2012 Aug; 30(8):1665-70. PubMed ID: 22728906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baroreflex activation therapy lowers arterial pressure without apparent stimulation of the carotid bodies.
    Alnima T; Goedhart EJ; Seelen R; van der Grinten CP; de Leeuw PW; Kroon AA
    Hypertension; 2015 Jun; 65(6):1217-22. PubMed ID: 25941348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Baroreflex Activation Therapy on Ambulatory Blood Pressure in Patients With Resistant Hypertension.
    Wallbach M; Lehnig LY; Schroer C; Lüders S; Böhning E; Müller GA; Wachter R; Koziolek MJ
    Hypertension; 2016 Apr; 67(4):701-9. PubMed ID: 26902491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An implantable carotid sinus stimulator for drug-resistant hypertension: surgical technique and short-term outcome from the multicenter phase II Rheos feasibility trial.
    Illig KA; Levy M; Sanchez L; Trachiotis GD; Shanley C; Irwin E; Pertile T; Kieval R; Cody R
    J Vasc Surg; 2006 Dec; 44(6):1213-1218. PubMed ID: 17145423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial.
    Bisognano JD; Bakris G; Nadim MK; Sanchez L; Kroon AA; Schafer J; de Leeuw PW; Sica DA
    J Am Coll Cardiol; 2011 Aug; 58(7):765-73. PubMed ID: 21816315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable carotid sinus stimulator for the treatment of resistant hypertension: local effects on carotid artery morphology.
    Sanchez LA; Illig K; Levy M; Trachiotis G; Shanley C; Irwin E; Jim J; Rossing M; Kieval R
    Ann Vasc Surg; 2010 Feb; 24(2):178-84. PubMed ID: 20036504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baroreflex activation therapy provides durable benefit in patients with resistant hypertension: results of long-term follow-up in the Rheos Pivotal Trial.
    Bakris GL; Nadim MK; Haller H; Lovett EG; Schafer JE; Bisognano JD
    J Am Soc Hypertens; 2012; 6(2):152-8. PubMed ID: 22341199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistant hypertension: baroreflex stimulation as a new tool.
    Menne J; Jordan J; Linnenweber-Held S; Haller H
    Nephrol Dial Transplant; 2013 Feb; 28(2):288-95. PubMed ID: 23223217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An implantable carotid sinus baroreflex activating system: surgical technique and short-term outcome from a multi-center feasibility trial for the treatment of resistant hypertension.
    Tordoir JH; Scheffers I; Schmidli J; Savolainen H; Liebeskind U; Hansky B; Herold U; Irwin E; Kroon AA; de Leeuw P; Peters TK; Kieval R; Cody R
    Eur J Vasc Endovasc Surg; 2007 Apr; 33(4):414-21. PubMed ID: 17227715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study.
    Scheffers IJ; Kroon AA; Schmidli J; Jordan J; Tordoir JJ; Mohaupt MG; Luft FC; Haller H; Menne J; Engeli S; Ceral J; Eckert S; Erglis A; Narkiewicz K; Philipp T; de Leeuw PW
    J Am Coll Cardiol; 2010 Oct; 56(15):1254-8. PubMed ID: 20883933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid baroreflex activation therapy for resistant hypertension.
    Victor RG
    Nat Rev Cardiol; 2015 Aug; 12(8):451-63. PubMed ID: 26149485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of renal denervation with a standard irrigated cardiac ablation catheter on blood pressure and renal function in patients with chronic kidney disease and resistant hypertension.
    Kiuchi MG; Maia GL; de Queiroz Carreira MA; Kiuchi T; Chen S; Andrea BR; Graciano ML; Lugon JR
    Eur Heart J; 2013 Jul; 34(28):2114-21. PubMed ID: 23786861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Baroreflex activation therapy in patients with prior renal denervation.
    Wallbach M; Halbach M; Reuter H; Passauer J; Lüders S; Böhning E; Zenker D; Müller GA; Wachter R; Koziolek MJ
    J Hypertens; 2016 Aug; 34(8):1630-8. PubMed ID: 27137174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass.
    Hildebrandt DA; Irwin ED; Lohmeier TE
    Hypertension; 2016 Dec; 68(6):1400-1406. PubMed ID: 27777356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral or unilateral stimulation for baroreflex activation therapy.
    de Leeuw PW; Alnima T; Lovett E; Sica D; Bisognano J; Haller H; Kroon AA
    Hypertension; 2015 Jan; 65(1):187-92. PubMed ID: 25331845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of baroreflex activation therapy on renal function--a pilot study.
    Wallbach M; Lehnig LY; Schroer C; Hasenfuss G; Müller GA; Wachter R; Koziolek MJ
    Am J Nephrol; 2014; 40(4):371-80. PubMed ID: 25358549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained Reduction of Blood Pressure With Baroreceptor Activation Therapy: Results of the 6-Year Open Follow-Up.
    de Leeuw PW; Bisognano JD; Bakris GL; Nadim MK; Haller H; Kroon AA;
    Hypertension; 2017 May; 69(5):836-843. PubMed ID: 28320856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chronic baroreceptor stimulation on the autonomic cardiovascular regulation in patients with drug-resistant arterial hypertension.
    Wustmann K; Kucera JP; Scheffers I; Mohaupt M; Kroon AA; de Leeuw PW; Schmidli J; Allemann Y; Delacrétaz E
    Hypertension; 2009 Sep; 54(3):530-6. PubMed ID: 19620513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A study on the outcome of percutaneous transluminal renal angioplasty in patients with renal failure.
    Roussos L; Christensson A; Thompson O
    Nephron Clin Pract; 2006; 104(3):c132-42. PubMed ID: 16899992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.